Gill Livingston from University College London states that, based on the 2024 Lancet Commission on Dementia Prevention, Intervention, and Care, diabetes is clearly identified as a key modifiable risk factor for dementia. Globally, there are now over 57 million people living with dementia, and this number is projected to triple by 2050. However, the decline […]
Tag: Dementia
Thomas van Sloten: Advocating for Dementia as a Core Outcome Measure in Diabetes Clinical Trials
Thomas van Sloten from Utrecht University in the Netherlands observes a rising prevalence of dementia among individuals with both Type 1 and Type 2 diabetes. He analyzes the underlying drivers and mitigation strategies, advocating that dementia should be integrated as a core outcome measure in clinical trials for diabetes treatments.In recent years, the global incidence […]